CVRx gets EU approval for novel treatment approach to hypertension

Neurostimulation seems to be the way that many companies, including Medtronic and St. Jude Medical, want to tackle high blood pressure or hypertension.But while these two public Minnesota companies developing new innovative medical devices have taken the renal denervation route where nerves in the kidney are deactivated, another Minnesota company is adopting a different approach [...]

[Read more of this report]


CVRx reports positive four-year results for its anti-blood pressure device

CVRx Inc. in Plymouth, Minn. said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years.In a study presented to the European Society of Hypertension meeting, the company said patients’ average systolic blood pressure dropped 27 percent to 140 mmHg (millimeters of mercury) from 193 mmHg [...]

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics